Medicine To Market News

🆕 789 new biotech/pharma jobs posted this morning ⏬ ⏬ ⏬ Here's a breakdown of how many per company ⏬ ⏬ ⏬ - - - - - And an update on our roadmap - - - - - We are adding more Categories to make search more efficient. There have been 6 Categories since launch... ...but you have asked us to slice this up more- 💡 example, carve out sales and marketing vs combined So, we have to make some system changes to make that happen 🛠️ Plan on it going live by the end of the month 👀 ⚠️ Again, we aren't recruiters for those wondering We are doing this to be helpful, especially considering that this past year has seen a major industry contraction with commercial and field being hit the most. Best of luck if you are searching ♻️ Please share with a friend that needs every advantage to find the next great gig ♻️ Today's breakdown: Agios Pharmaceuticals: 3 Akebia Therapeutics: 5 Alkermes: 13 Alnylam Pharmaceuticals: 1 Apellis Pharmaceuticals: 19 Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT): 1 Ardelyx, Inc.: 9 argenx: 16 Astria Therapeutics, Inc.: 1 BeiGene: 69 Biogen: 13 BioMarin Pharmaceutical Inc.: 20 Blueprint Medicines: 32 Boehringer Ingelheim: 17 BridgeBio: 33 Bristol Myers Squibb: 13 Cardiff Oncology: 2 Catalyst Pharmaceuticals, Inc.: 4 ClearPoint Neuro, Inc.: 1 Coherus BioSciences: 3 Corcept Therapeutics: 33 Crinetics Pharmaceuticals: 42 CRISPR Therapeutics: 2 Cytokinetics: 6 Day One Biopharmaceuticals: 2 embecta: 1 Esperion: 3 Exelixis: 18 Genmab: 12 GSK: 2 Insulet Corporation: 26 Ionis Pharmaceuticals, Inc.: 13 Jazz Pharmaceuticals: 23 KalVista Pharmaceuticals, Inc.: 3 Kiniksa Pharmaceuticals: 8 Madrigal Pharmaceuticals: 4 MannKind Corporation: 2 Merck: 32 Merus N.V.: 3 Moderna: 44 Novartis: 27 Pfizer: 8 PTC Therapeutics, Inc.: 9 Rhythm Pharmaceuticals Inc.: 13 Roivant: 3 Sanofi: 43 Sarepta Therapeutics: 23 Soleno Therapeutics, Inc.: 11 SpringWorks Therapeutics: 2 Summit Therapeutics, Inc.: 5 Supernus Pharmaceuticals, Inc.: 6 Syndax Pharmaceuticals: 4 Tandem Diabetes Care: 8 Tarsus Pharmaceuticals, Inc.: 6 Travere Therapeutics: 11 Ultragenyx: 9 UroGen Pharma: 6 Viatris: 9 Voyager Therapeutics, Inc.: 2 Zymeworks Inc.: 2 🔗 THE Link is in the first comment to open the Jobs section of Medicine To Market News #pharmajobs #biotechjobs #jobopening #jopbopportunity #careers #newjob

💸 $519,600 - If Novartis handed YOU this salary, would you TAKE it? 🏖️ Not sure if that will cover your addiction to long weekends in Grand Cayman??? ...I get it. Hold out for more 💲 But that kind of salary for a Therapeutic Area Strategy Head, Neuroscience job is pretty rich. Just think, you get the great taste of wide reaching responsibilities, a good size team, massive budget, for that comp package--- ---without all the calories of 🔹 being a small biotech/pharma CEO dealing with boards 🔸 impatient investors ⚠️ liabilities ranging from coffee maker accidents to Wall Street guidance. >>> Most small biopharma CEO's make less salary- to be clear <<< But THIS role... in a company this big is, say, VP level... ... a VP level title in big pharma isn't special, the people might be... but Novartis has over 1,000 of them. So there's a lot of them... kind of like Toyota Camrys on the morning commute 🚗 🚗 🚗 I think this job is compelling if you know how to evaluate pipeline, do BD and licensing, and enjoy the pressure of helping keep the company's future bright. I'll leave a link in the first comment. We have several new openings being posted this week so keep an eye on Medicine To Market News website- jobs section. ♻️ ♻️ ♻️ PS- we are NOT recruiters but we have a ton of tech to share a curated lists of jobs. If it helps you, consider helping me with a share so we can get more biopharma peeps in great roles and help make a difference for patients waiting for the next innovation they can create! ♻️ ♻️ ♻️ #pharmajobs #biotechjobs #jobopening #newjob #jobposting

Sales expansion coming soon! Pharma sales leaders... know one? They need to move FAST 🚴 🚴 🚴 Seriously, share this MANAGEMENT JOB listing with them b/c the market is tough. Other than Ionis Pharmaceuticals, Inc. earlier this year, I haven't seen many management expansions lately - Which makes this one a precious, and surely competitive, opportunity. Of the PDUFA's we are tracking, this drug has some great potential. If approved, Plozasiran could be a real game changer for a small set of patients That's the rare disease game 🧬 Small number of patients 🩺 Big impact 💥 4️⃣ They just posted 4 Regional Manager roles Northeast, Southeast, Central, and West. 💵 Salary range looks to be $175 to $225 First line management- big regions and soon big territories. 👀 So if you are a salesperson, watch for their field roles in the coming weeks. Advice- well, that's a tricky game... ...but we put together a backgrounder on the drug and market. I'll link it in the comments. ⬇️ ⬇️ ⬇️ But 2 things I would ask you to tell your manager friend applying for these roles- 1️⃣ - launches are always fun... rarely done well (based on market evidence) 2️⃣ - commercial leadership will shape the field culture (and this one has exceptional professionals like Janna Jagoe to make Arrowhead Pharmaceuticals a great place to perform) Good luck to the 4 lucky winners of these field management jobs. My guess is that they will get 50 highly qualified applicants for each... ... how many do you think will apply? 🎲 LMK in the comments- I love your feedback! #pharmajobs #biotechjobs #sales #salesjobs

🚀 Sharing a few notable new jobs in biopharma for you or your friends 🌠 All in the "almost $300k club" salary-wise. Up to $275,000 salary - Executive Director, National Sales - Vera Therapeutics, Inc. Kidneys need heroes. Spreadsheets need conquerors. Pro: Steer a rocketship biotech with late-stage therapies (atacicept = kidney disease’s nemesis) and a growth-focused culture. Stock options: check. Moral high ground: double-check. Con: Cash burn? Oh yeah—$46.6M net loss last quarter. Bring your own snacks (and maybe a financial therapist). Next job opening... 💉 $294,400 - Director, Global Oncology Marketing - Merck Pro: Command billion-dollar drug strategies at a dividend-doling giant (4% yield, friend). Perks? Think “I vacation better than you” tier. Con: Layoffs lurk like expired meds in the supply closet. Also, brace for PowerPoint purgatory. Last contestant for today's post... Up to $270,000 base 🤖 AVP of Sales - Tempus AI Sell tech that’s actually life-changing (not NFTs). Pro: Pitch AI tools trusted by 7k+ docs. Hybrid work, free caffeine, and a shot at making “precision medicine” more than a buzzword. Con: 401k match? 🤔 Some ex-employees have said, Nope. So, do your homework... ⚔️ Culture? Some say “Hunger Games with standing desks.” 💥 Tag/share with your ambitious friend (or frenemy). Applications > regrets. Links in comments if you want to look at these or 1,300 other jobs on Medicine To Market News website. #Hiring #Biotech #PharmaSales #pharmajobs #biotechjobs

💼 💰 📈 135 Pharma Sales Jobs to consider... ... and 1 to absolutely, undeniably, fervently AVOID ☣️ ☣️ ☣️ So here's the scoop- since we launched the Jobs section of the Medicine To Market News website traffic on the site has exploded. Which is good... ... until it's bad bad, because the traffic crashed the site for part of Thursday last week. Good, b/c it's fixed and pointed out upgrades we need to make. Plus, what's great is your feedback. We will launch a standalone field sales and accounts jobs engine because, frankly, people asked for it. So if that's different, what is the same? 😁 Glad you asked. 💡 The whole idea in doing this is to ease the burden of searching through clogged jobs aggregators that don't understand our industry. Plus, there is a VERY finite number of companies in biotech & pharma that real, weapons-grade executives (the kind I prefer to spend time with) would EVEN CONSIDER working at... ...THOSE are the companies we are tracking. And the companies I think are bad actors? They aren't on our list. Not to say every good company is in our list, that will continue to improve... ... but there are some that will be noticeably absent. Avoid those, IMHO. But the 135 sales roles across the US and listed right now... ... maybe take a peek at them if you are curious. ♻️ Or share them with people you respect that need a great new job. We hope you enjoy! ⤵️ ⤵️ Link in the first comment to see the job postings ⤵️ ⤵️ #pharmajobs #biotechjobs #newjob #careeropportunity #joblisting

🪧 3 New Vice President jobs just posted 💵 Salaries surprisingly low at: $245,000 - $320,000 USD 🧬 But the pipeline is the focus of every big pharma BD executive worth their approved flight upgrade to Economy Plus The Skinny on Kailera Therapeutics: Why You Should Care 1. The New Kid on the Block Kailera Therapeutics is not your granny's biotech company. With a recent $400 million Series A financing and a mission to transform obesity treatment, it's the new hotspot for ambitious execs looking for their next challenge. 2. The Power Team Ron Renaud, President and CEO (via Cerevel Therapeutics - AbbVie), and John F. Milligan (early employee at Gilead Sciences), Board Chair, are names you should know. They also just hired a first time CCO coming over from Eli Lilly and Company. Ron's record in leading companies to acquisition is undeniable. 3. The Future of Weight Management Kailera’s pipeline includes injectable and oral therapies that have shown promise in Phase 2 trials for obesity and type 2 diabetes. Incretins are red hot- and Pfizer has talked about interest in this general area. 4. New Roles to Watch - ⬇️ ⬇️ links in the first comment for your review ⬇️ ⬇️  - Vice President, Clinical Development:  - Vice President, Global Marketing  - Vice President, Global Value and Access 5. Why You Should Care Kailera Therapeutics is a company that's might make waves in the biotech world. With its $400 million backing and industry veterans at the helm, they have some cash and a need to build out the commercial function as their lead asset progresses through Phase 3 #pharmajobs #biotechjobs #vpjobs #jobopportunity #hiring